Hafoguard

Hafoguard

Pharmaceutical Products, OTC
Hafoguard
Hafoguard
Hafoguard

Information

Cancer and Chemotherapy can have a dual impact on patients. Hafoguard helps manage Chemotherapy-Induced Hand and Foot Syndrome with a specialized medical formulation. Hafoguard is a unique formulation with 20% UREA AND PENTAVITIN specifically designed for patients suffering from hand & foot syndrome. ✓The dual advantage of Urea and Pentavitin ensures "SUPERCHARGED HYDRATION" ✓ SAFE & EFFECTIVE" in management of Hand & Foot syndrome. ADVANTAGE OF 20% UREA Dermatologically Tested Formula KERATOLYTIC ACTIVITY: - Helps Improves Skin condition induced by Hand – foot syndrome such as Warts, Calluses Dry Skin. IDEAL HUMACTANT: - Helps Skin in Retaining Water and Keeping Skin Moist. HYDRATION ACTIVITY: - Helps in hydration of Nails, Prevents Drying and scaling. HAFOGUARD CREAM This non-greasy cream gives “ SUPER CHARGED HYDRATION “ in Hand and Foot Syndrome. Recommended to take a Patch Test before using the product regularly .100 % Natural and Plant Derived.
WeembraceS7.D35Weembrace is the UK arm of the Weembrace Group, a healthcare company focused on improving access to high-quality, affordable oncology therapies and supportive care. Our portfolio spans small-molecule oncology medicines alongside evidence-based onco-nutrition and onco-cosmeceutical solutions, enabling comprehensive support across the cancer pathway—from treatment to recovery.  Backed by 35+ years in pharmaceutical manufacturing, supply, and hospital distribution, Weembrace operates a controlled, quality-driven network serving government and private providers. Our partners’ facilities are WHO-GMP aligned and operate under robust SOPs covering sourcing, production, packaging, and logistics. We prioritize regulatory diligence and timely product registrations, working with local experts to ensure ethical commercialization and consistent quality in each market.  Weembrace maintains full regulatory compliance across states and supports large public-sector and institutional demand with dependable service levels. Internationally, we collaborate across the Middle East, Africa, Europe, and the CIS to strengthen access to essential oncology care.  At WHX Dubai, Weembrace Karevia is seeking distribution partners, hospital and pharmacy group buyers, and health-system stakeholders interested in reliable oncology supply, co-development of formulations, and market-appropriate nutrition and dermal support for oncology patients. Our goal is consistent: safer, dependable access to cancer care products at sustainable prices.

Log in

See all the content and easy-to-use features by logging in or registering!